Kidney Transplant: Rejection & Immunosuppression

Creator: Progress Note
Published: 2026-09-07
Keywords: kidney transplant, kidney transplant rejection, hyperacute acute chronic rejection, HLA matching, transplant immunosuppression, calcineurin inhibitors

bolt The 60-second version

check_circleTransplant is the best treatment for end-stage kidney disease.
check_circleABO and HLA matching reduce the risk of rejection.
check_circleHyperacute rejection (minutes) is from pre-formed antibodies.
check_circleAcute rejection (days to months) is cell- or antibody-mediated and often treatable.
check_circleLifelong immunosuppression (often a calcineurin inhibitor-based regimen) prevents rejection.

Indications and Matching

Kidney transplantation is offered for end-stage kidney disease and generally provides longer survival and better quality of life than long-term dialysis. Donors may be living or deceased. Compatibility is assessed by ABO blood typing, HLA (human leukocyte antigen) matching, and a crossmatch to detect pre-formed recipient antibodies against the donor. Better matching lowers the risk of rejection and prolongs graft survival.

Types of Rejection

Rejection is classified by timing and mechanism. Hyperacute rejection occurs within minutes from pre-formed antibodies against the graft and causes immediate thrombosis — now rare because of crossmatching. Acute rejection occurs days to months out and is T-cell-mediated and/or antibody-mediated, presenting with a rising creatinine; it is often reversible with treatment. Chronic rejection develops over months to years as progressive fibrosis and vascular changes, and responds poorly to therapy.

Immunosuppression

Preventing rejection requires lifelong immunosuppression, typically induction at the time of transplant followed by maintenance therapy. A common maintenance regimen combines a calcineurin inhibitor (tacrolimus or cyclosporine), an antimetabolite (mycophenolate), and a corticosteroid. Each has characteristic toxicities — calcineurin inhibitors are nephrotoxic, for example — so drug levels and side effects are carefully monitored.

Complications

Beyond rejection, transplant recipients face the consequences of immunosuppression: increased risk of infections, including opportunistic ones (CMV, Pneumocystis, BK virus) and reactivations, and an increased long-term risk of malignancy, especially skin cancers and post-transplant lymphoproliferative disorder. Recurrence of the original kidney disease and drug toxicities also threaten the graft, so recipients need lifelong monitoring.

Frequently asked questions

What are the types of kidney transplant rejection?expand_more

Hyperacute rejection happens within minutes from pre-formed antibodies (now rare due to crossmatching); acute rejection occurs days to months later and is T-cell and/or antibody-mediated and often treatable; and chronic rejection develops over months to years as progressive fibrosis that responds poorly to therapy.

Why is HLA matching important in kidney transplant?expand_more

HLA (human leukocyte antigen) matching, along with ABO typing and a crossmatch, reduces the immune system's recognition of the graft as foreign. Better matching lowers the risk of rejection and improves long-term graft survival.

What immunosuppression is used after a kidney transplant?expand_more

Recipients take lifelong immunosuppression, commonly a maintenance regimen of a calcineurin inhibitor (tacrolimus or cyclosporine), an antimetabolite (mycophenolate), and a corticosteroid, usually after induction therapy at transplant. Drug levels and toxicities are monitored closely.

What are the main risks after a kidney transplant?expand_more

The main risks are rejection and the effects of immunosuppression: increased infections (including opportunistic infections like CMV and BK virus) and higher long-term cancer risk, along with drug toxicities (calcineurin inhibitors are nephrotoxic) and possible recurrence of the original disease.

Free weekly high-yield email

One high-yield concept + one question, every week

Study smarter with a short weekly email. No spam — unsubscribe anytime.

Reading is one thing. Remembering is another.

Turn this guide into questions you’ll actually remember

Progress Note turns concepts like this into adaptive questions and spaced review, so difficult topics come back to you exactly when you’re about to forget them.

Practice this topic free arrow_forward Start a personalized study session